Prescription Drugs

The Rise of Gender-Affirmation Health Care Benefits

Anne Patterson
 

Gender-affirmation health care benefit offerings have been on the rise over the past seven years, according to survey data from the International Foundation. Up from 12 percent in 2016, 30 percent of U.S. employers now offer the benefit. I spoke with Julie […]

ACA Preventive Services Requirements Struck Down: Braidwood Management v. Becerra Explainer

Jenny Gartman, CEBS
 

As a result of ongoing litigation, the Departments of Labor (DOL), Health and Human Services (HHS), and the Treasury (the departments) cannot enforce some Affordable Care Act (ACA) preventive care requirements, but the departments strongly encourage plan sponsors to keep coverage without […]

Legal and Legislative Reporter: Court Denies Insurance Company’s Motion to Remand AD&D Benefits Claim

Guest Contributor
 

Every month, the International Foundation releases the Legal and Legislative Reporter, a compilation of new employee benefits-related case summaries. Below is a summary we thought you’d be interested in. Content provided by Morgan, Lewis & Bockius LLP. The U.S. District Court for the […]

RxDC Reporting Will Bring Changes . . . Here’s What to Know Now

Jonas Leyrer, CEBS
 

Late last year, Congress passed the Consolidated Appropriations Act, 2021 (CAA), which contained a provision requiring health care plans to submit Prescription Drug Data Collection (RxDC) reports to CMS. RxDC was made retroactive for 2020 but its implementation was delayed for a […]

Four Steps for Evaluating Your Plan’s Diabetes Coverage

Kathy Bergstrom, CEBS
 

Despite major advancements in technology and medication over the last four decades, people with diabetes still face barriers to getting the best care, a panel of experts said during an International Foundation webcast. Better health plan design can help remove those barriers […]